Effects of SARS-CoV-2 infection on incidence and treatment strategies of hepatocellular carcinoma in people with chronic liver disease
CONCLUSION: Although CLD patients with SARS-CoV-2 infection were not associated with increased risk of HCC, they were more likely to receive palliative treatment than those without. The detrimental effects of SARS-CoV-2 infection persisted in post-acute phase.PMID:38495273 | PMC:PMC10941734 | DOI:10.4254/wjh.v16.i2.211
Source: World Journal of Hepatology - Category: Gastroenterology Authors: Lung-Yi Mak Matthew Shing Hin Chung Xue Li Francisco Tsz Tsun Lai Eric Yuk Fai Wan Celine Sze Ling Chui Franco Wing Tak Cheng Esther Wai Yin Chan Ching Lung Cheung Ivan Chi Ho Au Xi Xiong Wai-Kay Seto Man-Fung Yuen Carlos King Ho Wong Ian Chi Kei Wong Source Type: research
More News: Cancer & Oncology | Carcinoma | Coronavirus | COVID-19 | Databases & Libraries | Gastroenterology | Hepatocellular Carcinoma | Hong Kong Health | Liver | Liver Cancer | Liver Disease | Palliative | Palliative Care | Respiratory Medicine | SARS | Urology & Nephrology